A detailed history of Srs Capital Advisors, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 102 shares of MRNA stock, worth $4,107. This represents 0.0% of its overall portfolio holdings.

Number of Shares
102
Previous 102 -0.0%
Holding current value
$4,107
Previous $12,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$101.21 - $166.61 $20,039 - $32,988
-198 Reduced 66.0%
102 $12,000
Q1 2024

May 14, 2024

BUY
$85.37 - $115.44 $25,611 - $34,632
300 New
300 $31,000
Q3 2021

Nov 05, 2021

SELL
$221.9 - $484.47 $110,950 - $242,235
-500 Closed
0 $0
Q2 2021

Aug 02, 2021

BUY
$129.91 - $234.98 $64,955 - $117,490
500 New
500 $117,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Srs Capital Advisors, Inc. Portfolio

Follow Srs Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.